Business Description
Intech Biopharm Ltd
ISIN : TW0006461007
Total Employee Number:
87Description
Intech Biopharm Ltd is engaged in pharmaceutical R&D and sales. The company focuses on the development and manufacturing of new combinations, new formulations, and generic drugs with high barriers for the treatment of respiratory diseases. It owns the patented MDI platform iLEF (Inhaled Low Ethanol Formulation). The company operates in a single-industry segment, mainly engaged in R&D of technology and sale of pharmaceuticals.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 1.08 | |||||
Debt-to-EBITDA | -4.62 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.44 | |||||
Beneish M-Score | 1.71 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 52.5 | |||||
3-Year EBITDA Growth Rate | 3 | |||||
3-Year EPS without NRI Growth Rate | 2.5 | |||||
3-Year FCF Growth Rate | -18 | |||||
3-Year Book Growth Rate | -10 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.57 | |||||
9-Day RSI | 42.82 | |||||
14-Day RSI | 44.71 | |||||
3-1 Month Momentum % | -15.47 | |||||
6-1 Month Momentum % | -30.61 | |||||
12-1 Month Momentum % | -22.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.66 | |||||
Quick Ratio | 1.18 | |||||
Cash Ratio | 0.88 | |||||
Days Inventory | 191.03 | |||||
Days Sales Outstanding | 19.91 | |||||
Days Payable | 15.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.5 | |||||
Shareholder Yield % | -15.88 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -103.18 | |||||
Operating Margin % | -338.99 | |||||
Net Margin % | -361.8 | |||||
EBITDA Margin % | -239.42 | |||||
FCF Margin % | -395.38 | |||||
OCF Margin % | -335.85 | |||||
ROE % | -40.84 | |||||
ROA % | -15.75 | |||||
ROIC % | -15.78 | |||||
3-Year ROIIC % | 17.82 | |||||
ROC (Joel Greenblatt) % | -20.89 | |||||
ROCE % | -16.76 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 20.99 | |||||
PB Ratio | 2.5 | |||||
Price-to-Tangible-Book | 2.52 | |||||
EV-to-EBIT | -10.7 | |||||
EV-to-EBITDA | -14.49 | |||||
EV-to-Revenue | 34.68 | |||||
EV-to-FCF | -9.05 | |||||
Price-to-GF-Value | 0.18 | |||||
Earnings Yield (Greenblatt) % | -9.35 | |||||
FCF Yield % | -15.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Intech Biopharm Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 107.527 | ||
| EPS (TTM) (NT$) | -2.509 | ||
| Beta | -0.5265 | ||
| 3-Year Sharpe Ratio | -0.67 | ||
| 3-Year Sortino Ratio | -0.85 | ||
| Volatility % | 48.03 | ||
| 14-Day RSI | 44.71 | ||
| 14-Day ATR (NT$) | 0.591274 | ||
| 20-Day SMA (NT$) | 15.5075 | ||
| 12-1 Month Momentum % | -22.73 | ||
| 52-Week Range (NT$) | 14.1 - 26.25 | ||
| Shares Outstanding (Mil) | 178.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Intech Biopharm Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Intech Biopharm Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Intech Biopharm Ltd Frequently Asked Questions
What is Intech Biopharm Ltd(ROCO:6461)'s stock price today?
The current price of ROCO:6461 is NT$15.45. The 52 week high of ROCO:6461 is NT$26.25 and 52 week low is NT$14.10.
When is next earnings date of Intech Biopharm Ltd(ROCO:6461)?
The next earnings date of Intech Biopharm Ltd(ROCO:6461) is .
Does Intech Biopharm Ltd(ROCO:6461) pay dividends? If so, how much?
Intech Biopharm Ltd(ROCO:6461) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Intech Biopharm Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers